HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Cardiology452 papers

Respiratory complication

Last edited: 4/26/2026

Overview

Respiratory complications during pregnancy encompass a range of conditions that affect maternal respiratory health, including but not limited to gestational hypertension, preeclampsia, gestational diabetes mellitus (GDM), and respiratory distress syndromes. These complications are clinically significant due to their potential to cause severe maternal morbidity, neonatal complications, and long-term health implications for both mothers and their offspring. They disproportionately affect women with pre-existing conditions such as hypertension, diabetes, and obesity, as well as those experiencing nutritional deficiencies or immune dysregulation during pregnancy. Understanding and managing these complications is crucial in day-to-day practice to mitigate adverse outcomes and ensure optimal health for both mother and child 123456789101112.

Pathophysiology

The pathophysiology of respiratory complications during pregnancy often involves a complex interplay of systemic inflammation, metabolic dysregulation, and placental dysfunction. Elevated pre-pregnancy blood pressure and metabolic markers like the triglyceride-glucose (TyG) index can predispose women to gestational hypertension and preeclampsia, characterized by endothelial dysfunction and increased oxidative stress 2312. Similarly, gestational diabetes mellitus (GDM) arises from insulin resistance, which can exacerbate metabolic disturbances and affect placental function, potentially leading to respiratory complications such as respiratory distress syndromes 3412. Inflammation during pregnancy, particularly in early gestation, disrupts normal immune tolerance mechanisms, contributing to adverse obstetric outcomes including preterm birth and hypertensive disorders 8. These processes collectively impair placental perfusion and maternal organ function, particularly affecting the respiratory system through mechanisms like increased pulmonary vascular resistance and fluid shifts 147.

Epidemiology

The incidence of respiratory complications during pregnancy varies but is notable for its increasing trend, particularly among women with pre-existing non-communicable diseases (NCDs) and those living in resource-limited settings. Globally, gestational hypertension affects up to 10% of pregnancies, while GDM impacts approximately 14% of pregnancies worldwide 2310. In low- and middle-income countries, anemia among pregnant women further complicates these issues, with prevalence rates as high as 45%, contributing to adverse outcomes such as post-partum hemorrhage and preterm birth 17. Geographic disparities exist, with higher burdens observed in regions with poorer healthcare infrastructure and higher rates of NCDs 1710. Trends indicate an increasing prevalence of these complications, likely driven by rising obesity rates, delayed childbearing, and improved diagnostic capabilities 2310.

Clinical Presentation

Respiratory complications during pregnancy can present with a spectrum of symptoms, ranging from subtle to severe. Common manifestations include hypertension, proteinuria (in preeclampsia), and signs of metabolic derangement such as polyuria and polydipsia in GDM. Respiratory symptoms may manifest as dyspnea, tachypnea, or signs of respiratory distress, particularly in cases of severe preeclampsia or acute respiratory distress syndrome (ARDS). Red-flag features include severe headache, visual disturbances, epigastric pain, and sudden onset of hypertension, which necessitate urgent evaluation 1234567891011. Early detection often relies on routine prenatal screening for blood pressure, glucose levels, and other metabolic markers, alongside clinical vigilance for atypical presentations 1234567891011.

Diagnosis

The diagnostic approach for respiratory complications during pregnancy involves a combination of clinical assessment, laboratory tests, and monitoring physiological changes specific to pregnancy. Key diagnostic criteria include:

  • Hypertensive Disorders of Pregnancy (HDP):
    • - Blood Pressure ≥ 140/90 mmHg on two occasions at least four hours apart 123. - Proteinuria (≥ 0.3 g/dL in a 24-hour urine sample or dipstick positive) 123. - Additional features like thrombocytopenia, elevated liver enzymes, or renal impairment for severe cases (eclampsia) 123.

  • Gestational Diabetes Mellitus (GDM):
    • - Oral Glucose Tolerance Test (OGTT) with fasting glucose < 126 mg/dL, but ≥ 140 mg/dL at 2 hours 3410. - HbA1c ≥ 6.5% in some settings, though this is less commonly used in pregnancy 3410.

  • Respiratory Distress:
    • - Clinical signs: Tachypnea (RR > 20 breaths/min), use of accessory muscles, hypoxemia (SpO2 < 95% on room air) 567. - Chest imaging (X-ray or CT) may show signs of pulmonary edema or other respiratory compromise 567.

    Differential Diagnosis:

  • Chronic Hypertension: Persistent hypertension before pregnancy without additional features of preeclampsia 12.
  • Chronic Kidney Disease: Elevated creatinine or proteinuria without hypertension or other preeclampsia features 12.
  • Thyroid Disorders: Hypothyroidism or hyperthyroidism presenting with hypertension or metabolic disturbances 123.

    • Management

    First-Line Management

  • Hypertensive Disorders of Pregnancy (HDP):
    • - Blood Pressure Control: Labetalol or Nifedipine for acute management; target BP < 160/110 mmHg initially 123. - Magnesium Sulfate: For seizure prophylaxis in severe cases (eclampsia) 123. - Monitoring: Frequent antenatal visits, blood pressure checks, and proteinuria assessments 123.

  • Gestational Diabetes Mellitus (GDM):
    • - Diet and Lifestyle Modifications: Structured meal plans, increased physical activity (as tolerated) 610. - Glycemic Control: Insulin therapy if necessary, aiming for fasting glucose < 95 mg/dL and postprandial < 120 mg/dL 3410.

    Second-Line Management

  • Refractory Hypertension:
    • - Alternative Antihypertensives: Consider adding or switching to other agents like hydralazine or methyldopa 123. - Close Monitoring: Regular fetal monitoring, maternal electrolytes, and renal function 123.

  • Poorly Controlled GDM:
    • - Insulin Adjustments: Titrate insulin doses based on glucose monitoring results 3410. - Multidisciplinary Support: Endocrinology consultation for complex cases 3410.

    Specialist Escalation

  • Severe Preeclampsia/Eclampsia:
    • - Magnesium Sulfate Therapy: Continuous infusion for seizure control 123. - Delivery Consideration: Timing based on gestational age and maternal/fetal stability 123.

  • Respiratory Distress:
    • - Hospital Admission: For close monitoring and supportive care including oxygen therapy 567. - Specialist Referral: Pulmonology consultation for persistent or severe respiratory issues 567.

    Contraindications:

  • Antihypertensives: Avoid ACE inhibitors and ARBs due to fetal renal impairment risk 123.
  • Insulin Therapy: Monitor for hypoglycemia, especially in GDM management 3410.

    • Complications

    Acute Complications

  • Maternal: Acute respiratory distress syndrome (ARDS), severe preeclampsia leading to eclampsia, HELLP syndrome 567.
  • Fetal/Neonatal: Intrauterine growth restriction (IUGR), preterm birth, respiratory distress syndrome, low birth weight 1234567.

    • Long-Term Complications

  • Maternal: Increased risk of chronic hypertension, cardiovascular disease, and type 2 diabetes post-pregnancy 123414.
  • Fetal/Child: Long-term metabolic issues, including obesity and insulin resistance, impacting future health outcomes 34101214.

    • Management Triggers:

  • Close Monitoring: Regular follow-ups and timely intervention for persistent hypertension or hyperglycemia 123410.
  • Referral: Specialist care for recurrent or severe complications 56714.

    • Prognosis & Follow-Up

    The prognosis for women experiencing respiratory complications during pregnancy varies based on the severity and management efficacy. Prognostic indicators include timely diagnosis, adherence to treatment plans, and control of underlying conditions. Recommended follow-up intervals typically include:

  • Immediate Postpartum: Blood pressure, glucose levels, and general health assessment within 6-8 weeks postpartum 123410.
  • Long-Term Monitoring: Annual evaluations for chronic hypertension, diabetes, and cardiovascular health, especially for those with a history of HDP or GDM 123414.

    • Special Populations

    Pregnancy

  • Gestational Weight Gain (GWG): Excessive or inadequate GWG significantly influences the risk of HDP and GDM 11. Monitoring and counseling on optimal GWG are crucial 11.
  • Physical Activity: Regular moderate-intensity exercise can reduce the risk of APOs; adherence to WHO guidelines is recommended 6.

    • Comorbidities

  • Anemia: High prevalence among pregnant women; iron supplementation and nutritional support are essential 17.
  • Immune Activation: Women with heightened inflammatory markers may require closer monitoring for adverse outcomes 8.

    • Geographic and Socioeconomic Factors

  • Low-Resource Settings: Higher maternal mortality rates linked to inadequate antenatal care and limited access to specialized services 79. Enhanced surveillance and community-based interventions are vital 79.

    • Key Recommendations

  • Screen for HDP and GDM Early and Regularly: Implement routine blood pressure and glucose monitoring throughout pregnancy (Evidence: Strong) 123410.
  • Optimize Gestational Weight Gain: Provide individualized counseling to achieve recommended GWG targets (Evidence: Moderate) 11.
  • Promote Physical Activity: Encourage moderate exercise as per WHO guidelines to reduce APOs (Evidence: Moderate) 6.
  • Manage Hypertension with Safe Antihypertensives: Use labetalol or nifedipine for BP control in HDP (Evidence: Strong) 123.
  • Insulin Therapy for GDM: Initiate insulin when lifestyle modifications fail to control glucose levels (Evidence: Strong) 3410.
  • Monitor for Respiratory Distress: Frequent assessments for signs of respiratory compromise, especially in severe cases (Evidence: Moderate) 567.
  • Postpartum Follow-Up: Schedule comprehensive evaluations within 6-8 weeks postpartum to assess recovery and long-term risks (Evidence: Moderate) 123410.
  • Address Anemia: Provide iron supplementation and nutritional support to pregnant women (Evidence: Strong) 17.
  • Enhance Antenatal Care Access: Improve coverage and quality of antenatal services, particularly in low-resource settings (Evidence: Moderate) 79.
  • Evaluate Immune Markers: Consider early pregnancy inflammatory markers for high-risk women to predict adverse outcomes (Evidence: Moderate) 8.

    • References

    Showing 100 priority papers (full text preferred, most recent first) of 390 indexed.

    1 Votruba N, Majumdar S, Raj ST, Nayak V, Sharma A, Peiris D et al.. Protocol for a process and implementation evaluation of the SMARThealth pregnancy hybrid type 2 cluster randomised controlled trial. Women's health (London, England) 2026. link 2 Jung YJ, Kim T, Kim YH. Elevated Pre-Pregnancy Blood Pressure and the Risk of Adverse Pregnancy Outcomes: Evidence From a Nationwide Population-Based Study. Journal of Korean medical science 2025. link 3 He X, He X, Zhou Y, Liu J, Wang G. Associations between triglyceride-glucose index in the early trimester of pregnancy and adverse pregnancy outcomes. BMC pregnancy and childbirth 2025. link 4 Cui J, Jiang H, Huang F, Xie M, Cui Z, Chen X et al.. First-trimester triglyceride-glucose index and birth weight: a retrospective cohort mediation analysis of preterm birth and gestational complications. BMC pregnancy and childbirth 2025. link 5 Bendaham LCAR, Neto APM, Faria HS, Filho ARDSO, Ferreira CHO, Cunha MDSK et al.. Respiratory outcomes of adrenergic beta-antagonists in patients undergoing tracheal extubation: a systematic review and meta-analysis of randomized controlled trials. Brazilian journal of anesthesiology (Elsevier) 2025. link 6 Slapgaard LV, Stafne SN, Rangul V, Dahle IA, Horn J. Device measured physical activity before pregnancy and the risk of adverse pregnancy outcomes in the HUNT study: a population-based cohort study. BMC pregnancy and childbirth 2025. link 7 Singu BS, Maketo M, Siwombe M. Comorbidities and prescribed medications in expectant mothers attending antenatal clinic: a cross-sectional study in Windhoek, Namibia. Primary health care research & development 2025. link 8 Gigase FAJ, Boekhorst MMGBM, Suleri A, Rommel AS, Breen M, Muetzel RL et al.. Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population-Based Cohort Study. BJOG : an international journal of obstetrics and gynaecology 2025. link 9 Cutipa Vásquez Melgar EA, Flores Palacios RJ. Systolic hypertension, caesarean duration and prenatal visits as predictors of maternal near miss in Peru. International health 2025. link 10 Zhao Z, Chang T, Liu X, Zhang X, Liu X, Zhang Y et al.. Association between dietary intakes and pregnancy complications: a two-sample Mendelian randomization analysis. BMC pregnancy and childbirth 2025. link 11 Yan Q, Cai W, Guo Y. The influence of maternal gestational weight gain on adverse perinatal outcomes. Frontiers in endocrinology 2025. link 12 Kinsey EW, Caceres OM, Posner HEK, Hinkle SN. Food insecurity during pregnancy and associated perinatal outcomes: a scoping review. Epidemiologic reviews 2025. link 13 Meng Z, Lin M, Song L, Chen Y, Deng S, Xia S et al.. The first-trimester triglyceride glucose-body mass index is a valuable predictor for adverse pregnancy outcomes. BMC pregnancy and childbirth 2025. link 14 Fisher M, Smith G, Potter BK, Arbuckle TE, Little J, Weiler H et al.. The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study. The Journal of clinical endocrinology and metabolism 2025. link 15 Slade L, Blackman M, Mistry HD, Bone JN, Wilson M, Syeda N et al.. Diagnostic properties of differing BP thresholds for adverse pregnancy outcomes in standard-risk nulliparous women: A secondary analysis of SCOPE cohort data. PLoS medicine 2025. link 16 Furuya S, Yamaguchi T, Ishikawa I, Ishikawa M, Kawanami R, Kasano S et al.. Singleton term pregnancies resulting from frozen-thawed embryo transfer in hormone replacement cycles increase the risk of aberrant placentation, including velamentous umbilical cord insertion. Archives of gynecology and obstetrics 2025. link 17 Schreiber H, Cohen G, Markovitch O, Weitzner O, Farladansky-Gershnabel S, Biron-Shental T et al.. Is there an association between lateral uterine localization of the placenta and pregnancy outcomes?. Archives of gynecology and obstetrics 2025. link 18 Lin L, Sun B, Wang X, Zhang R, Lin J, Yan J. The mediating effects of gestational diabetes mellitus and hypertensive disorders of pregnancy between maternal advanced age, previous caesarean section and the risk of small- or large-for-gestational-age newborns: a multicentric prospective cohort study in southern China. Journal of global health 2025. link 19 Koirala P, Koirala I, Pun S, Karna S. Effect of Interpregnancy Interval on Pregnancy Outcome in a Tertiary Care Centre: A Descriptive Cross-sectional Study. JNMA; journal of the Nepal Medical Association 2024. link 20 Lin X, Zhou L, Si S, Cheng H, Alifu X, Qiu Y et al.. Association of the comorbidity of gestational diabetes mellitus and hypertension disorders of pregnancy with birth outcomes. Frontiers in endocrinology 2024. link 21 Tang L, Luo Y, Sheng Y, Lai T, Song W, Yang X et al.. Hemoglobin concentrations in early pregnancy and their associations with adverse pregnancy outcomes in Western China: a population-based study. BMC pregnancy and childbirth 2024. link 22 Galan R, Pembrey L, Bustamante M, Aguilar R, Mason D, Vidal M et al.. The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts. BMC pregnancy and childbirth 2024. link 23 Abera EG, Gudina EK, Gebremichael EH, Sori DA, Yilma D. Double burden of gestational diabetes and pregnancy-induced hypertension in Ethiopia: A systematic review and meta-analysis of observational studies. PloS one 2024. link 24 Jackson K, Karasek D, Gemmill A, Collin DF, Hamad R. Maternal Health During the COVID-19 Pandemic in the United States: An Interrupted Time-series Analysis. Epidemiology (Cambridge, Mass.) 2024. link 25 Naowar M, Dickton D, Francis J. Cardiometabolic Risk Factors Associated with Magnesium and Vitamin D Nutrients during Pregnancy-A Narrative Review. Nutrients 2024. link 26 Ha LC, Naqvi M, Conley P, Bairey Merz CN, Barone Gibbs B, Levine LD et al.. Activity restriction and risk of adverse pregnancy outcomes. American journal of obstetrics & gynecology MFM 2024. link 27 Marincowitz GJO, Marincowitz C. Causes of stillbirths at Kgapane hospital, Limpopo province. South African family practice : official journal of the South African Academy of Family Practice/Primary Care 2024. link 28 Mforteh AAA, Pisoh DW, Boten M, Andoh NE, Tameh TY, Mbi-Kobenge AE et al.. Stillbirth rate and associated factors at the Bamenda Regional hospital, North-West region, Cameroon, from 2018 to 2022: a case control study. BMC pregnancy and childbirth 2024. link 29 Schowe AM, Czamara D, Lahti-Pulkkinen M, Girchenko P, Castro-Quintas Á, Fañanas L et al.. Serial Diurnal Salivary Cortisol Profiles in 667 Pregnant Women-Association With Cardiometabolic Complications. The Journal of clinical endocrinology and metabolism 2024. link 30 Conrad KP, von Versen-Höynck F, Baker VL. Pathologic maternal and neonatal outcomes associated with programmed embryo transfer. Journal of assisted reproduction and genetics 2024. link 31 Wilson MG, Bone JN, Mistry HD, Slade LJ, Singer J, von Dadelszen P et al.. Blood Pressure and Heart Rate Variability and the Impact on Pregnancy Outcomes: A Systematic Review. Journal of the American Heart Association 2024. link 32 Mirieri H, Nduati R, Dawa J, Okutoyi L, Osoro E, Mugo C et al.. Risk factors of adverse birth outcomes among a cohort of pregnant women in Coastal Kenya, 2017-2019. BMC pregnancy and childbirth 2024. link 33 Ivošević T, Miličić B, Trivić A, Bukurov B, Arsović N, Slijepčević N et al.. PREDICTORS OF INTRAOPERATIVE HYPERTENSION IN NECK SURGERY: A SINGLE CENTER RETROSPECTIVE STUDY. Acta clinica Croatica 2023. link 34 Garanet F, Samadoulougou S, Ngwasiri C, Coulibaly A, B Sissoko F, Bagnoa VN et al.. Perinatal outcomes in women with lower-range elevated blood pressure and stage 1 hypertension: insights from the Kaya health and demographic surveillance system, Burkina Faso. BMC public health 2023. link 35 Nawsherwan, Liu Z, Le Z, Mubarik S, Sun Y, Naeem S et al.. The adverse effect of gestational diabetes mellitus and hypertensive disorders of pregnancy on maternal-perinatal outcomes among singleton and twin pregnancies: a retrospective cohort study (2011-2019). Frontiers in endocrinology 2023. link 36 Hao H, Yoo SR, Strickland MJ, Darrow LA, D'Souza RR, Warren JL et al.. Effects of air pollution on adverse birth outcomes and pregnancy complications in the U.S. state of Kansas (2000-2015). Scientific reports 2023. link 37 Zhou Y, Yin S, Sheng Q, Yang J, Liu J, Li H et al.. Association of maternal age with adverse pregnancy outcomes: A prospective multicenter cohort study in China. Journal of global health 2023. link 38 Mehta M, Basu R, Ghosh R. Adverse effects of temperature on perinatal and pregnancy outcomes: methodological challenges and knowledge gaps. Frontiers in public health 2023. link 39 Zhang Y, Qian Y, Liu C, Fan X, Li X, Song Y et al.. Association between white blood cell count and adverse pregnancy outcomes: a retrospective cohort study from a tertiary hospital in China. BMJ open 2023. link 40 Ding M, Markon AO, Jones-Dominic OE, Purdue-Smithe AC, Rich-Edwards JW, Wolpert BJ et al.. Intake of Energy Drinks Before and During Pregnancy and Adverse Pregnancy Outcomes. JAMA network open 2023. link 41 Li K, Hu Z, Li W, Shah K, Sessler D. Tight perioperative blood pressure management to reduce complications: a randomised feasibility trial. BMJ open 2023. link 42 Wang S, Mitsunami M, Ortiz-Panozo E, Leung CW, Manson JE, Rich-Edwards JW et al.. Prepregnancy Healthy Lifestyle and Adverse Pregnancy Outcomes. Obstetrics and gynecology 2023. link 43 Hu X, Liao Z, Li J, Zhou Y, Guo Y, Qian K. Young women were associated with higher risk of hypertensive disorders of pregnancy and cesarean section from hormone replaced cycles in frozen-thawed embryo transfer: a retrospective study of 5316 singleton deliveries. Frontiers in endocrinology 2023. link 44 Zhao Z, Chen Y, Deng H, Huang L, Lu D, Shen X et al.. The influence of embryo stage on obstetric complications and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Frontiers in endocrinology 2023. link 45 Hirst JE, Votruba N, Billot L, Arora V, Rajan E, Thout SR et al.. A community-based intervention to improve screening, referral and follow-up of non-communicable diseases and anaemia amongst pregnant and postpartum women in rural India: study protocol for a cluster randomised trial. Trials 2023. link 46 Zhang J, Du M, Wang Z, Wu S, Guan Y, Sun L. The duration of estrogen treatment before progesterone application does not affect neonatal and perinatal outcomes in frozen embryo transfer cycles. Frontiers in endocrinology 2023. link 47 Badeghiesh A, Hochberg A, Elsherbini N, Baghlaf H, Dahan MH. How does IVF conception affect pregnancy complications in an older cohort of women, at least 38 years of age? Study of a population database. Journal of assisted reproduction and genetics 2023. link 48 Younger A, Alkon A, Harknett K, Kirby MA, Elon L, Lovvorn AE et al.. Effects of a LPG stove and fuel intervention on adverse maternal outcomes: A multi-country randomized controlled trial conducted by the Household Air Pollution Intervention Network (HAPIN). Environment international 2023. link 49 Arruda Correia ML, Peixoto Filho FM, Gomes Júnior SC, Peixoto MVM. Effects of intra-abdominal hypertension on maternal-fetal outcomes in term pregnant women: A systematic review. PloS one 2023. link 50 Lane A, Wilcox S, Wingard E, McLean MK, Liu J. Association of a Lifestyle Intervention with Blood Pressure Trajectories During Pregnancy and Postpartum in Women with Pre-pregnancy Overweight and Obesity. Maternal and child health journal 2023. link 51 Blanco E, Ruiz-Rudolph P, Yohannessen K, Ayala S, Quinteros ME, Delgado-Saborit JM et al.. Temporal and Spatial Trends of Adverse Pregnancy and Birth Outcomes in a Sample of Births from a Public Hospital in Chile. Journal of urban health : bulletin of the New York Academy of Medicine 2023. link 52 Hinkle SN, Schisterman EF, Liu D, Pollack AZ, Yeung EH, Mumford SL et al.. Pregnancy Complications and Long-Term Mortality in a Diverse Cohort. Circulation 2023. link 53 Oben A, Moore M, Wallace E, Muntner P, Oparil S, Tita A et al.. Validation of a Remote Monitoring Blood Pressure Device in Pregnancy. American journal of hypertension 2023. link 54 Fisher SC, Van Zutphen AR, Romitti PA, Browne ML. Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011. Maternal and child health journal 2018. link 55 Liu S, Ruan Q, Dai Z, Chen F, Shi Y. Exploring the causal association between pre-pregnancy obesity and pregnancy-related complications, and mediating pathways of obesity on adverse pregnancy outcomes: Insights from Mendelian randomization analysis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2025. link 56 Marsh D, Mathes M, Miller A, Menard K, Sayles H, Carlson K. Stage I hypertension and pregnancy: Scope of disease and pregnancy outcomes. Pregnancy hypertension 2025. link 57 Baird F, Smith E, Beebeejaun Y, Subramanian V, Bhaduri M, Kametas N et al.. Obstetric and perinatal outcomes in singleton pregnancies following medicated, stimulated and natural, frozen embryo transfer cycles: an updated systematic review and meta-analysis. Human fertility (Cambridge, England) 2025. link 58 Greco M, Calgaro G, Cavallo M, Pugliese S, Mascari M, Piccirillo F et al.. Brain-targeted goal-directed therapy in high-risk patients undergoing major elective surgery: Study protocol for the BRAIN-PROMISE randomized trial. Contemporary clinical trials 2025. link 59 Dong W, Chu X, Wang Y, Gu L, Chen Y. Association of Maternal Serum Retinol-Binding Protein Levels with Adverse Pregnancy Outcomes: A Retrospective Cohort Study. American journal of perinatology 2025. link 60 Baran JV, Rohatgi A, Redden A, Fomunung C, Goguen J, John DQ et al.. Do modifiable patient factors increase the risk of postoperative complications after total joint arthroplasty?. Archives of orthopaedic and trauma surgery 2024. link 61 Hu M, Liang S, Wu Q, Shin Lee C, Lu J, Bao S et al.. Association between changes in glycosylated hemoglobin during the second and third trimesters and adverse pregnancy outcomes among women without hyperglycemia in pregnancy. Diabetes research and clinical practice 2024. link 62 Piazza CL, Doyle LW, Pascoe L, Mainzer RM, Takagi M, Cheong JL et al.. Twenty four-hour blood pressure and cognitive outcomes in adolescents born extremely preterm and at term. Acta paediatrica (Oslo, Norway : 1992) 2024. link 63 Zhang J, Zhou Y, Yu G, Li J, Cao Y, Li L et al.. Elevated maternal serum bile acids level, hypertensive disorders of pregnancy and adverse fetal outcomes: a cohort study of 117,789 pregnant women in China. Clinica chimica acta; international journal of clinical chemistry 2024. link 64 Mackeen AD, Boyd VE, Schuster M, Young AJ, Gray C, Angras K. The impact of prepregnancy body mass index on pregnancy and neonatal outcomes. Journal of osteopathic medicine 2024. link 65 Golbasi H, Bayraktar B, Golbasi C, Omeroglu I, Adiyaman D, Alkan KO et al.. Association between fetal fraction of cell-free DNA and adverse pregnancy outcomes. Archives of gynecology and obstetrics 2024. link 66 Pennington EL, Barner JC, Brown CM, Lawson KA. Pregnancy-related risk factors and receipt of postpartum care among Texas Medicaid pregnant enrollees: Opportunities for pharmacist services. Journal of the American Pharmacists Association : JAPhA 2024. link 67 Keepanasseril A, Maurya DK, Velmurugan B, Karuppusamy D, Pillai AA, Parameswaran S et al.. Impact of near-miss event during pregnancy and childbirth on maternal health at 12 months. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2024. link 68 Başkiran Y, Uçkan K, Çeleğen I. Effect of grand multiparity on maternal, obstetric, fetal and neonatal results. European review for medical and pharmacological sciences 2023. link 69 Eckler R, Liu YD, Pooni A, Yong PJ, Lisonkova S, Bedaiwy MA. Maternal and perinatal outcomes in primiparous singleton pregnancies conceived with assisted reproductive technology in British Columbia. European journal of obstetrics, gynecology, and reproductive biology 2023. link 70 Oliveira D, de Oliveira JM, Martins MDR, Barroso MR, Castro R, Cordeiro L et al.. Maternal Profiles and Pregnancy Outcomes: A Descriptive Cross-Sectional Study from Angola. Maternal and child health journal 2023. link 71 Conway KS, Menclova AK. You'll never walk alone - The effects of walkability on pregnancy behaviors and outcomes. Economics and human biology 2023. link 72 Gebremedhin AT, Regan AK, Håberg SE, Luke Marinovich M, Tessema GA, Pereira G. The influence of birth outcomes and pregnancy complications on interpregnancy interval: a quantile regression analysis. Annals of epidemiology 2023. link 73 Sugai S, Sekizuka T, Haino K, Nonaka T, Sekine M, Yoshihara K et al.. Obstetrical outcomes of pregnant women 50 years and older compared to those aged 45-49 years: A systematic review and meta-analysis. The journal of obstetrics and gynaecology research 2023. link 74 Hartwell M, Keener A, Robling K, Enmeier M, Sajjadi NB, Greiner B et al.. Associations of intimate partner violence and maternal comorbidities: a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System. Journal of osteopathic medicine 2023. link 75 Carbone L, Raffone A, Travaglino A, Saccone G, Di Girolamo R, Neola D et al.. The impact of COVID-19 pandemic on obstetrics and gynecology hospitalization rate and on reasons for seeking emergency care: a systematic review and meta-analysis. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2023. link 76 Rajkumar T, Hennessy A, Ali Y, Makris A. Clinical characteristics and sequelae of intrapartum hypertension - a retrospective cohort study. BMC pregnancy and childbirth 2023. link 77 Ji H, Zhang MQ, Zhou Q, Zhang S, Dong L, Li XL et al.. Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes. BMC pregnancy and childbirth 2023. link 78 Asltoghiri M, Moghaddam-Banaem L, Behboudi-Gandevani S, Rahimi Froushani A, Ramezani Tehrani F. Prediction of adverse pregnancy outcomes by first-trimester components of metabolic syndrome: a prospective longitudinal study. Archives of gynecology and obstetrics 2023. link 79 Lang M, Zhou M, Lei R, Li W. Comparison of pregnancy outcomes between IVF-ET pregnancies and spontaneous pregnancies in women of advanced maternal age. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2023. link 80 Ladd-Acosta C, Vang E, Barrett ES, Bulka CM, Bush NR, Cardenas A et al.. Analysis of Pregnancy Complications and Epigenetic Gestational Age of Newborns. JAMA network open 2023. link 81 Bernardo DS, Carvalho CB, Conde M, Mota JA, Santos PC. Effectiveness of a structured exercise intervention in gestational weight gain in pregnant women with overweight and obesity: A systematic review with meta-analysis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2023. link 82 Afolabi-Oboirien KO, Panti AA, Tunau KA, Ukwu AE, Abdulrahman MB, Garba JA. Microalbuminuria and its association with adverse pregnancy outcome in a tertiary health centre in Nigeria. The Nigerian postgraduate medical journal 2023. link 83 Cheung KW, Seto MT, Wang W, So PL, Hui ASY, Yu FN et al.. Characteristics of Maternal Mortality Missed by Vital Statistics in Hong Kong, 2000-2019. JAMA network open 2023. link 84 Huang C, Jiang Q, Su W, Lv F, Zeng J, Huang P et al.. Age-specific effects on adverse pregnancy outcomes vary by maternal characteristics: a population-based retrospective study in Xiamen, China. BMC public health 2023. link 85 Slade LJ, Wilson M, Mistry HD, Bone JN, Bello NA, Blackman M et al.. The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes. American journal of obstetrics and gynecology 2023. link 86 Elhakeem A, Ronkainen J, Mansell T, Lange K, Mikkola TM, Mishra BH et al.. Effect of common pregnancy and perinatal complications on offspring metabolic traits across the life course: a multi-cohort study. BMC medicine 2023. link 87 Chauhan BG, Chokhandre PK, Kulaste BS, Sivanandan V. Burden of Anaemia, Hypertension and Diabetes among pregnant women in India. Journal of biosocial science 2023. link 88 Thompson NN, Mumuni K, Oppong SA, Sefogah PE, Nuamah MA, Nkyekyer K. Effect of intimate partner violence in pregnancy on maternal and perinatal outcomes at the Korle Bu teaching hospital, Ghana: An observational cross sectional study. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2023. link 89 Changalidis AI, Maksiutenko EM, Barbitoff YA, Tkachenko AA, Vashukova ES, Pachuliia OV et al.. Aggregation of Genome-Wide Association Data from FinnGen and UK Biobank Replicates Multiple Risk Loci for Pregnancy Complications. Genes 2022. link 90 Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C et al.. Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study. PloS one 2022. link 91 David AL, Spencer RN. Clinical Assessment of Fetal Well-Being and Fetal Safety Indicators. Journal of clinical pharmacology 2022. link 92 Sintayehu Y, Abera L, Sema A, Belay Y, Guta A, Amsalu B et al.. Factors associated with neonatal near miss among neonates admitted to public hospitals in dire Dawa administration, Eastern Ethiopia: A case-control study. PloS one 2022. link 93 Ajong AB, Kenfack B, Ali IM, Yakum MN, Ukaogo PO, Mangala FN et al.. Adverse maternofoetal outcomes associated with ionised calcaemia, total calcaemia, albuminaemia, and calcium supplementation in pregnancy: Analysis from a resource-limited setting. PloS one 2022. link 94 Rosenberg J, Sude L, Budge M, León-Martínez D, Fenick A, Altice FL et al.. Rapid Deployment of a Mobile Medical Clinic During the COVID-19 Pandemic: Assessment of Dyadic Maternal-Child Care. Maternal and child health journal 2022. link 95 Chainoglou A, Sarafidis K, Chrysaidou K, Farmaki E, Kollios K, Economou M et al.. Arterial stiffness and nocturnal hypertension in preterm children and adolescents. Journal of hypertension 2022. link 96 Lin D, Huang X, Fan D, Chen G, Li P, Rao J et al.. Association of Optimal Gestational Weight Gain Ranges With Perinatal Outcomes Across Body Mass Index Categories in Twin Pregnancies. JAMA network open 2022. link 97 Yisahak SF, Hinkle SN, Mumford SL, Gleason JL, Grantz KL, Zhang C et al.. Periconceptional and First Trimester Ultraprocessed Food Intake and Maternal Cardiometabolic Outcomes. Diabetes care 2022. link 98 Heinonen E, Forsberg L, Nörby U, Wide K, Källén K. Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study. BMJ open 2022. link 99 Frey HA, Ashmead R, Farmer A, Kim YH, Shellhaas C, Oza-Frank R et al.. Association of Prepregnancy Body Mass Index With Risk of Severe Maternal Morbidity and Mortality Among Medicaid Beneficiaries. JAMA network open 2022. link 100 Ushida T, Nakamura N, Nakatochi M, Kobayashi Y, Sato Y, Iitani Y et al.. Impact of hypertensive disorders of pregnancy on respiratory outcomes in extremely and very preterm infants: A population-based study in Japan. Pregnancy hypertension 2022. link

    Original source

    1. [1]
      Protocol for a process and implementation evaluation of the SMARThealth pregnancy hybrid type 2 cluster randomised controlled trial. — Votruba N, Majumdar S, Raj ST, Nayak V, Sharma A, Peiris D et al. Women's health (London, England) (2026)
    2. [2]
      Elevated Pre-Pregnancy Blood Pressure and the Risk of Adverse Pregnancy Outcomes: Evidence From a Nationwide Population-Based Study. — Jung YJ, Kim T, Kim YH Journal of Korean medical science (2025)
    3. [3]
      Associations between triglyceride-glucose index in the early trimester of pregnancy and adverse pregnancy outcomes. — He X, He X, Zhou Y, Liu J, Wang G BMC pregnancy and childbirth (2025)
    4. [4]
      First-trimester triglyceride-glucose index and birth weight: a retrospective cohort mediation analysis of preterm birth and gestational complications. — Cui J, Jiang H, Huang F, Xie M, Cui Z, Chen X et al. BMC pregnancy and childbirth (2025)
    5. [5]
      Respiratory outcomes of adrenergic beta-antagonists in patients undergoing tracheal extubation: a systematic review and meta-analysis of randomized controlled trials. — Bendaham LCAR, Neto APM, Faria HS, Filho ARDSO, Ferreira CHO, Cunha MDSK et al. Brazilian journal of anesthesiology (Elsevier) (2025)
    6. [6]
      Device measured physical activity before pregnancy and the risk of adverse pregnancy outcomes in the HUNT study: a population-based cohort study. — Slapgaard LV, Stafne SN, Rangul V, Dahle IA, Horn J BMC pregnancy and childbirth (2025)
    7. [7]
      Comorbidities and prescribed medications in expectant mothers attending antenatal clinic: a cross-sectional study in Windhoek, Namibia. — Singu BS, Maketo M, Siwombe M Primary health care research & development (2025)
    8. [8]
      Maternal Immune Activation During Pregnancy and Obstetric Outcomes: A Population-Based Cohort Study. — Gigase FAJ, Boekhorst MMGBM, Suleri A, Rommel AS, Breen M, Muetzel RL et al. BJOG : an international journal of obstetrics and gynaecology (2025)
    9. [9]
      Systolic hypertension, caesarean duration and prenatal visits as predictors of maternal near miss in Peru. — Cutipa Vásquez Melgar EA, Flores Palacios RJ International health (2025)
    10. [10]
      Association between dietary intakes and pregnancy complications: a two-sample Mendelian randomization analysis. — Zhao Z, Chang T, Liu X, Zhang X, Liu X, Zhang Y et al. BMC pregnancy and childbirth (2025)
    11. [11]
      The influence of maternal gestational weight gain on adverse perinatal outcomes. — Yan Q, Cai W, Guo Y Frontiers in endocrinology (2025)
    12. [12]
      Food insecurity during pregnancy and associated perinatal outcomes: a scoping review. — Kinsey EW, Caceres OM, Posner HEK, Hinkle SN Epidemiologic reviews (2025)
    13. [13]
      The first-trimester triglyceride glucose-body mass index is a valuable predictor for adverse pregnancy outcomes. — Meng Z, Lin M, Song L, Chen Y, Deng S, Xia S et al. BMC pregnancy and childbirth (2025)
    14. [14]
      The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study. — Fisher M, Smith G, Potter BK, Arbuckle TE, Little J, Weiler H et al. The Journal of clinical endocrinology and metabolism (2025)
    15. [15]
      Diagnostic properties of differing BP thresholds for adverse pregnancy outcomes in standard-risk nulliparous women: A secondary analysis of SCOPE cohort data. — Slade L, Blackman M, Mistry HD, Bone JN, Wilson M, Syeda N et al. PLoS medicine (2025)
    16. [16]
      Singleton term pregnancies resulting from frozen-thawed embryo transfer in hormone replacement cycles increase the risk of aberrant placentation, including velamentous umbilical cord insertion. — Furuya S, Yamaguchi T, Ishikawa I, Ishikawa M, Kawanami R, Kasano S et al. Archives of gynecology and obstetrics (2025)
    17. [17]
      Is there an association between lateral uterine localization of the placenta and pregnancy outcomes? — Schreiber H, Cohen G, Markovitch O, Weitzner O, Farladansky-Gershnabel S, Biron-Shental T et al. Archives of gynecology and obstetrics (2025)
    18. [18]
      The mediating effects of gestational diabetes mellitus and hypertensive disorders of pregnancy between maternal advanced age, previous caesarean section and the risk of small- or large-for-gestational-age newborns: a multicentric prospective cohort study in southern China. — Lin L, Sun B, Wang X, Zhang R, Lin J, Yan J Journal of global health (2025)
    19. [19]
      Effect of Interpregnancy Interval on Pregnancy Outcome in a Tertiary Care Centre: A Descriptive Cross-sectional Study. — Koirala P, Koirala I, Pun S, Karna S JNMA; journal of the Nepal Medical Association (2024)
    20. [20]
      Association of the comorbidity of gestational diabetes mellitus and hypertension disorders of pregnancy with birth outcomes. — Lin X, Zhou L, Si S, Cheng H, Alifu X, Qiu Y et al. Frontiers in endocrinology (2024)
    21. [21]
      Hemoglobin concentrations in early pregnancy and their associations with adverse pregnancy outcomes in Western China: a population-based study. — Tang L, Luo Y, Sheng Y, Lai T, Song W, Yang X et al. BMC pregnancy and childbirth (2024)
    22. [22]
      The association of Helicobacter pylori with adverse pregnancy outcomes in three European birth cohorts. — Galan R, Pembrey L, Bustamante M, Aguilar R, Mason D, Vidal M et al. BMC pregnancy and childbirth (2024)
    23. [23]
      Double burden of gestational diabetes and pregnancy-induced hypertension in Ethiopia: A systematic review and meta-analysis of observational studies. — Abera EG, Gudina EK, Gebremichael EH, Sori DA, Yilma D PloS one (2024)
    24. [24]
      Maternal Health During the COVID-19 Pandemic in the United States: An Interrupted Time-series Analysis. — Jackson K, Karasek D, Gemmill A, Collin DF, Hamad R Epidemiology (Cambridge, Mass.) (2024)
    25. [25]
      Cardiometabolic Risk Factors Associated with Magnesium and Vitamin D Nutrients during Pregnancy-A Narrative Review. — Naowar M, Dickton D, Francis J Nutrients (2024)
    26. [26]
      Activity restriction and risk of adverse pregnancy outcomes. — Ha LC, Naqvi M, Conley P, Bairey Merz CN, Barone Gibbs B, Levine LD et al. American journal of obstetrics & gynecology MFM (2024)
    27. [27]
      Causes of stillbirths at Kgapane hospital, Limpopo province. — Marincowitz GJO, Marincowitz C South African family practice : official journal of the South African Academy of Family Practice/Primary Care (2024)
    28. [28]
      Stillbirth rate and associated factors at the Bamenda Regional hospital, North-West region, Cameroon, from 2018 to 2022: a case control study. — Mforteh AAA, Pisoh DW, Boten M, Andoh NE, Tameh TY, Mbi-Kobenge AE et al. BMC pregnancy and childbirth (2024)
    29. [29]
      Serial Diurnal Salivary Cortisol Profiles in 667 Pregnant Women-Association With Cardiometabolic Complications. — Schowe AM, Czamara D, Lahti-Pulkkinen M, Girchenko P, Castro-Quintas Á, Fañanas L et al. The Journal of clinical endocrinology and metabolism (2024)
    30. [30]
      Pathologic maternal and neonatal outcomes associated with programmed embryo transfer. — Conrad KP, von Versen-Höynck F, Baker VL Journal of assisted reproduction and genetics (2024)
    31. [31]
      Blood Pressure and Heart Rate Variability and the Impact on Pregnancy Outcomes: A Systematic Review. — Wilson MG, Bone JN, Mistry HD, Slade LJ, Singer J, von Dadelszen P et al. Journal of the American Heart Association (2024)
    32. [32]
      Risk factors of adverse birth outcomes among a cohort of pregnant women in Coastal Kenya, 2017-2019. — Mirieri H, Nduati R, Dawa J, Okutoyi L, Osoro E, Mugo C et al. BMC pregnancy and childbirth (2024)
    33. [33]
      PREDICTORS OF INTRAOPERATIVE HYPERTENSION IN NECK SURGERY: A SINGLE CENTER RETROSPECTIVE STUDY. — Ivošević T, Miličić B, Trivić A, Bukurov B, Arsović N, Slijepčević N et al. Acta clinica Croatica (2023)
    34. [34]
      Perinatal outcomes in women with lower-range elevated blood pressure and stage 1 hypertension: insights from the Kaya health and demographic surveillance system, Burkina Faso. — Garanet F, Samadoulougou S, Ngwasiri C, Coulibaly A, B Sissoko F, Bagnoa VN et al. BMC public health (2023)
    35. [35]
      The adverse effect of gestational diabetes mellitus and hypertensive disorders of pregnancy on maternal-perinatal outcomes among singleton and twin pregnancies: a retrospective cohort study (2011-2019). — Nawsherwan, Liu Z, Le Z, Mubarik S, Sun Y, Naeem S et al. Frontiers in endocrinology (2023)
    36. [36]
      Effects of air pollution on adverse birth outcomes and pregnancy complications in the U.S. state of Kansas (2000-2015). — Hao H, Yoo SR, Strickland MJ, Darrow LA, D'Souza RR, Warren JL et al. Scientific reports (2023)
    37. [37]
      Association of maternal age with adverse pregnancy outcomes: A prospective multicenter cohort study in China. — Zhou Y, Yin S, Sheng Q, Yang J, Liu J, Li H et al. Journal of global health (2023)
    38. [38]
      Adverse effects of temperature on perinatal and pregnancy outcomes: methodological challenges and knowledge gaps. — Mehta M, Basu R, Ghosh R Frontiers in public health (2023)
    39. [39]
      Association between white blood cell count and adverse pregnancy outcomes: a retrospective cohort study from a tertiary hospital in China. — Zhang Y, Qian Y, Liu C, Fan X, Li X, Song Y et al. BMJ open (2023)
    40. [40]
      Intake of Energy Drinks Before and During Pregnancy and Adverse Pregnancy Outcomes. — Ding M, Markon AO, Jones-Dominic OE, Purdue-Smithe AC, Rich-Edwards JW, Wolpert BJ et al. JAMA network open (2023)
    41. [41]
      Tight perioperative blood pressure management to reduce complications: a randomised feasibility trial. — Li K, Hu Z, Li W, Shah K, Sessler D BMJ open (2023)
    42. [42]
      Prepregnancy Healthy Lifestyle and Adverse Pregnancy Outcomes. — Wang S, Mitsunami M, Ortiz-Panozo E, Leung CW, Manson JE, Rich-Edwards JW et al. Obstetrics and gynecology (2023)
    43. [43]
      Young women were associated with higher risk of hypertensive disorders of pregnancy and cesarean section from hormone replaced cycles in frozen-thawed embryo transfer: a retrospective study of 5316 singleton deliveries. — Hu X, Liao Z, Li J, Zhou Y, Guo Y, Qian K Frontiers in endocrinology (2023)
    44. [44]
      The influence of embryo stage on obstetric complications and perinatal outcomes following programmed compared to natural frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. — Zhao Z, Chen Y, Deng H, Huang L, Lu D, Shen X et al. Frontiers in endocrinology (2023)
    45. [45]
      A community-based intervention to improve screening, referral and follow-up of non-communicable diseases and anaemia amongst pregnant and postpartum women in rural India: study protocol for a cluster randomised trial. — Hirst JE, Votruba N, Billot L, Arora V, Rajan E, Thout SR et al. Trials (2023)
    46. [46]
      The duration of estrogen treatment before progesterone application does not affect neonatal and perinatal outcomes in frozen embryo transfer cycles. — Zhang J, Du M, Wang Z, Wu S, Guan Y, Sun L Frontiers in endocrinology (2023)
    47. [47]
      How does IVF conception affect pregnancy complications in an older cohort of women, at least 38 years of age? Study of a population database. — Badeghiesh A, Hochberg A, Elsherbini N, Baghlaf H, Dahan MH Journal of assisted reproduction and genetics (2023)
    48. [48]
      Effects of a LPG stove and fuel intervention on adverse maternal outcomes: A multi-country randomized controlled trial conducted by the Household Air Pollution Intervention Network (HAPIN). — Younger A, Alkon A, Harknett K, Kirby MA, Elon L, Lovvorn AE et al. Environment international (2023)
    49. [49]
      Effects of intra-abdominal hypertension on maternal-fetal outcomes in term pregnant women: A systematic review. — Arruda Correia ML, Peixoto Filho FM, Gomes Júnior SC, Peixoto MVM PloS one (2023)
    50. [50]
      Association of a Lifestyle Intervention with Blood Pressure Trajectories During Pregnancy and Postpartum in Women with Pre-pregnancy Overweight and Obesity. — Lane A, Wilcox S, Wingard E, McLean MK, Liu J Maternal and child health journal (2023)
    51. [51]
      Temporal and Spatial Trends of Adverse Pregnancy and Birth Outcomes in a Sample of Births from a Public Hospital in Chile. — Blanco E, Ruiz-Rudolph P, Yohannessen K, Ayala S, Quinteros ME, Delgado-Saborit JM et al. Journal of urban health : bulletin of the New York Academy of Medicine (2023)
    52. [52]
      Pregnancy Complications and Long-Term Mortality in a Diverse Cohort. — Hinkle SN, Schisterman EF, Liu D, Pollack AZ, Yeung EH, Mumford SL et al. Circulation (2023)
    53. [53]
      Validation of a Remote Monitoring Blood Pressure Device in Pregnancy. — Oben A, Moore M, Wallace E, Muntner P, Oparil S, Tita A et al. American journal of hypertension (2023)
    54. [54]
      Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011. — Fisher SC, Van Zutphen AR, Romitti PA, Browne ML Maternal and child health journal (2018)
    55. [55]
      Exploring the causal association between pre-pregnancy obesity and pregnancy-related complications, and mediating pathways of obesity on adverse pregnancy outcomes: Insights from Mendelian randomization analysis. — Liu S, Ruan Q, Dai Z, Chen F, Shi Y International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2025)
    56. [56]
      Stage I hypertension and pregnancy: Scope of disease and pregnancy outcomes. — Marsh D, Mathes M, Miller A, Menard K, Sayles H, Carlson K Pregnancy hypertension (2025)
    57. [57]
      Obstetric and perinatal outcomes in singleton pregnancies following medicated, stimulated and natural, frozen embryo transfer cycles: an updated systematic review and meta-analysis. — Baird F, Smith E, Beebeejaun Y, Subramanian V, Bhaduri M, Kametas N et al. Human fertility (Cambridge, England) (2025)
    58. [58]
      Brain-targeted goal-directed therapy in high-risk patients undergoing major elective surgery: Study protocol for the BRAIN-PROMISE randomized trial. — Greco M, Calgaro G, Cavallo M, Pugliese S, Mascari M, Piccirillo F et al. Contemporary clinical trials (2025)
    59. [59]
      Association of Maternal Serum Retinol-Binding Protein Levels with Adverse Pregnancy Outcomes: A Retrospective Cohort Study. — Dong W, Chu X, Wang Y, Gu L, Chen Y American journal of perinatology (2025)
    60. [60]
      Do modifiable patient factors increase the risk of postoperative complications after total joint arthroplasty? — Baran JV, Rohatgi A, Redden A, Fomunung C, Goguen J, John DQ et al. Archives of orthopaedic and trauma surgery (2024)
    61. [61]
      Association between changes in glycosylated hemoglobin during the second and third trimesters and adverse pregnancy outcomes among women without hyperglycemia in pregnancy. — Hu M, Liang S, Wu Q, Shin Lee C, Lu J, Bao S et al. Diabetes research and clinical practice (2024)
    62. [62]
      Twenty four-hour blood pressure and cognitive outcomes in adolescents born extremely preterm and at term. — Piazza CL, Doyle LW, Pascoe L, Mainzer RM, Takagi M, Cheong JL et al. Acta paediatrica (Oslo, Norway : 1992) (2024)
    63. [63]
      Elevated maternal serum bile acids level, hypertensive disorders of pregnancy and adverse fetal outcomes: a cohort study of 117,789 pregnant women in China. — Zhang J, Zhou Y, Yu G, Li J, Cao Y, Li L et al. Clinica chimica acta; international journal of clinical chemistry (2024)
    64. [64]
      The impact of prepregnancy body mass index on pregnancy and neonatal outcomes. — Mackeen AD, Boyd VE, Schuster M, Young AJ, Gray C, Angras K Journal of osteopathic medicine (2024)
    65. [65]
      Association between fetal fraction of cell-free DNA and adverse pregnancy outcomes. — Golbasi H, Bayraktar B, Golbasi C, Omeroglu I, Adiyaman D, Alkan KO et al. Archives of gynecology and obstetrics (2024)
    66. [66]
      Pregnancy-related risk factors and receipt of postpartum care among Texas Medicaid pregnant enrollees: Opportunities for pharmacist services. — Pennington EL, Barner JC, Brown CM, Lawson KA Journal of the American Pharmacists Association : JAPhA (2024)
    67. [67]
      Impact of near-miss event during pregnancy and childbirth on maternal health at 12 months. — Keepanasseril A, Maurya DK, Velmurugan B, Karuppusamy D, Pillai AA, Parameswaran S et al. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)
    68. [68]
      Effect of grand multiparity on maternal, obstetric, fetal and neonatal results. — Başkiran Y, Uçkan K, Çeleğen I European review for medical and pharmacological sciences (2023)
    69. [69]
      Maternal and perinatal outcomes in primiparous singleton pregnancies conceived with assisted reproductive technology in British Columbia. — Eckler R, Liu YD, Pooni A, Yong PJ, Lisonkova S, Bedaiwy MA European journal of obstetrics, gynecology, and reproductive biology (2023)
    70. [70]
      Maternal Profiles and Pregnancy Outcomes: A Descriptive Cross-Sectional Study from Angola. — Oliveira D, de Oliveira JM, Martins MDR, Barroso MR, Castro R, Cordeiro L et al. Maternal and child health journal (2023)
    71. [71]
      You'll never walk alone - The effects of walkability on pregnancy behaviors and outcomes. — Conway KS, Menclova AK Economics and human biology (2023)
    72. [72]
      The influence of birth outcomes and pregnancy complications on interpregnancy interval: a quantile regression analysis. — Gebremedhin AT, Regan AK, Håberg SE, Luke Marinovich M, Tessema GA, Pereira G Annals of epidemiology (2023)
    73. [73]
      Obstetrical outcomes of pregnant women 50 years and older compared to those aged 45-49 years: A systematic review and meta-analysis. — Sugai S, Sekizuka T, Haino K, Nonaka T, Sekine M, Yoshihara K et al. The journal of obstetrics and gynaecology research (2023)
    74. [74]
      Associations of intimate partner violence and maternal comorbidities: a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System. — Hartwell M, Keener A, Robling K, Enmeier M, Sajjadi NB, Greiner B et al. Journal of osteopathic medicine (2023)
    75. [75]
      The impact of COVID-19 pandemic on obstetrics and gynecology hospitalization rate and on reasons for seeking emergency care: a systematic review and meta-analysis. — Carbone L, Raffone A, Travaglino A, Saccone G, Di Girolamo R, Neola D et al. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2023)
    76. [76]
      Clinical characteristics and sequelae of intrapartum hypertension - a retrospective cohort study. — Rajkumar T, Hennessy A, Ali Y, Makris A BMC pregnancy and childbirth (2023)
    77. [77]
      Trophectoderm biopsy is associated with adverse obstetric outcomes rather than neonatal outcomes. — Ji H, Zhang MQ, Zhou Q, Zhang S, Dong L, Li XL et al. BMC pregnancy and childbirth (2023)
    78. [78]
      Prediction of adverse pregnancy outcomes by first-trimester components of metabolic syndrome: a prospective longitudinal study. — Asltoghiri M, Moghaddam-Banaem L, Behboudi-Gandevani S, Rahimi Froushani A, Ramezani Tehrani F Archives of gynecology and obstetrics (2023)
    79. [79]
      Comparison of pregnancy outcomes between IVF-ET pregnancies and spontaneous pregnancies in women of advanced maternal age. — Lang M, Zhou M, Lei R, Li W The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians (2023)
    80. [80]
      Analysis of Pregnancy Complications and Epigenetic Gestational Age of Newborns. — Ladd-Acosta C, Vang E, Barrett ES, Bulka CM, Bush NR, Cardenas A et al. JAMA network open (2023)
    81. [81]
      Effectiveness of a structured exercise intervention in gestational weight gain in pregnant women with overweight and obesity: A systematic review with meta-analysis. — Bernardo DS, Carvalho CB, Conde M, Mota JA, Santos PC International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2023)
    82. [82]
      Microalbuminuria and its association with adverse pregnancy outcome in a tertiary health centre in Nigeria. — Afolabi-Oboirien KO, Panti AA, Tunau KA, Ukwu AE, Abdulrahman MB, Garba JA The Nigerian postgraduate medical journal (2023)
    83. [83]
      Characteristics of Maternal Mortality Missed by Vital Statistics in Hong Kong, 2000-2019. — Cheung KW, Seto MT, Wang W, So PL, Hui ASY, Yu FN et al. JAMA network open (2023)
    84. [84]
      Age-specific effects on adverse pregnancy outcomes vary by maternal characteristics: a population-based retrospective study in Xiamen, China. — Huang C, Jiang Q, Su W, Lv F, Zeng J, Huang P et al. BMC public health (2023)
    85. [85]
      The 2017 American College of Cardiology and American Heart Association blood pressure categories in the second half of pregnancy-a systematic review of their association with adverse pregnancy outcomes. — Slade LJ, Wilson M, Mistry HD, Bone JN, Bello NA, Blackman M et al. American journal of obstetrics and gynecology (2023)
    86. [86]
      Effect of common pregnancy and perinatal complications on offspring metabolic traits across the life course: a multi-cohort study. — Elhakeem A, Ronkainen J, Mansell T, Lange K, Mikkola TM, Mishra BH et al. BMC medicine (2023)
    87. [87]
      Burden of Anaemia, Hypertension and Diabetes among pregnant women in India. — Chauhan BG, Chokhandre PK, Kulaste BS, Sivanandan V Journal of biosocial science (2023)
    88. [88]
      Effect of intimate partner violence in pregnancy on maternal and perinatal outcomes at the Korle Bu teaching hospital, Ghana: An observational cross sectional study. — Thompson NN, Mumuni K, Oppong SA, Sefogah PE, Nuamah MA, Nkyekyer K International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2023)
    89. [89]
      Aggregation of Genome-Wide Association Data from FinnGen and UK Biobank Replicates Multiple Risk Loci for Pregnancy Complications. — Changalidis AI, Maksiutenko EM, Barbitoff YA, Tkachenko AA, Vashukova ES, Pachuliia OV et al. Genes (2022)
    90. [90]
      Cannabis use in pregnancy and maternal and infant outcomes: A Canadian cross-jurisdictional population-based cohort study. — Luke S, Hobbs AJ, Smith M, Riddell C, Murphy P, Agborsangaya C et al. PloS one (2022)
    91. [91]
      Clinical Assessment of Fetal Well-Being and Fetal Safety Indicators. — David AL, Spencer RN Journal of clinical pharmacology (2022)
    92. [92]
      Factors associated with neonatal near miss among neonates admitted to public hospitals in dire Dawa administration, Eastern Ethiopia: A case-control study. — Sintayehu Y, Abera L, Sema A, Belay Y, Guta A, Amsalu B et al. PloS one (2022)
    93. [93]
      Adverse maternofoetal outcomes associated with ionised calcaemia, total calcaemia, albuminaemia, and calcium supplementation in pregnancy: Analysis from a resource-limited setting. — Ajong AB, Kenfack B, Ali IM, Yakum MN, Ukaogo PO, Mangala FN et al. PloS one (2022)
    94. [94]
      Rapid Deployment of a Mobile Medical Clinic During the COVID-19 Pandemic: Assessment of Dyadic Maternal-Child Care. — Rosenberg J, Sude L, Budge M, León-Martínez D, Fenick A, Altice FL et al. Maternal and child health journal (2022)
    95. [95]
      Arterial stiffness and nocturnal hypertension in preterm children and adolescents. — Chainoglou A, Sarafidis K, Chrysaidou K, Farmaki E, Kollios K, Economou M et al. Journal of hypertension (2022)
    96. [96]
      Association of Optimal Gestational Weight Gain Ranges With Perinatal Outcomes Across Body Mass Index Categories in Twin Pregnancies. — Lin D, Huang X, Fan D, Chen G, Li P, Rao J et al. JAMA network open (2022)
    97. [97]
      Periconceptional and First Trimester Ultraprocessed Food Intake and Maternal Cardiometabolic Outcomes. — Yisahak SF, Hinkle SN, Mumford SL, Gleason JL, Grantz KL, Zhang C et al. Diabetes care (2022)
    98. [98]
      Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study. — Heinonen E, Forsberg L, Nörby U, Wide K, Källén K BMJ open (2022)
    99. [99]
      Association of Prepregnancy Body Mass Index With Risk of Severe Maternal Morbidity and Mortality Among Medicaid Beneficiaries. — Frey HA, Ashmead R, Farmer A, Kim YH, Shellhaas C, Oza-Frank R et al. JAMA network open (2022)
    100. [100]
      Impact of hypertensive disorders of pregnancy on respiratory outcomes in extremely and very preterm infants: A population-based study in Japan. — Ushida T, Nakamura N, Nakatochi M, Kobayashi Y, Sato Y, Iitani Y et al. Pregnancy hypertension (2022)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG